SHENYANG, China, May 4 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. , a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release financial results for the first quarter ended March 31, 2009 after the US market closes on Tuesday, May 19, 2009.
Following the earnings announcement, 3SBio’s senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on Wednesday, May 20, 2009 to discuss its 2009 first quarter financial results and recent business activity.
A telephone replay will be available shortly after the call until May 27, 2009, at:
A live webcast of the conference call and the replay will be available on the investor relations page of 3SBio’s website at http://bbs.3sbio.com/en/News/xinvestors.aspx .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.
For more information, please visit 3SBio on the web at http://www.3sbio.com .
CONTACT: Investor Contact: Bo Tan, CFO, 3SBio Inc. at +86-24-2581-1820;
Investor Relations (China): Peter Schmidt, FD Beijing at +86-10-8591-1953;
Investor Relations (US): Evan Smith & John Capodanno, FD US at
+1-212-850-5600
Web site: http://www.3sbio.com/
http://bbs.3sbio.com/en/News/xinvestors.aspx//
